fashion -WSS

fashion

author：fashion 2025-09-06 04:13:09 - browse：613

Thomas Massie -- health policy coverage from STAT — Rep. Thomas Massie (R-Ky.) Kevin Dietsch/Getty Images

WASHINGTON — House lawmakers late Tuesday voted to attach a U.S. ban on controversial infectious disease research to legislation that could ultimately fund federal health agencies like the National Institutes of Health.

The bill would bar any federal agencies from funding so-called gain-of-function research, which involves altering a pathogen to study its spread, potentially making it more transmissible or severe in the process.

The spending bill already included a restriction on funding this research in any country determined to be a “foreign adversary,” including China. Scientists at the Wuhan Institute of Virology studied gain-of-function in some viruses, fueling theories that the Covid-19 pathogen was a lab leak. Those theories have never definitively been proven.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Shkreli is convicted of fraud. Can pharma finally slam the door on him?

WSS

Why failed clinical trials don’t always spell doom for a new drug

NIH trials fail to test meaningful long Covid therapies, experts say

Wegovy trial has doctors encouraged over new possibilities

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Wegovy trial has doctors encouraged over new possibilities

South Korea throws huge K

explore

fashion

hotspot

Medicare details structure of new drug price negotiation program

The best solution to the drug shortages problem

Jerome Adams on the need for new antivirals for Covid

Drastic changes should bring profitability, startup health insurers say

Sports medicine is finally prioritizing gender equality

A biotech analyst on neuroscience, placebo effect, not over

Sports medicine is finally prioritizing gender equality

Anavex keeps shifting the goalposts in its clinical trials

Psychedelics group wrestles with new pharma identity

For Cytokinetics, FDA rejection of heart drug would help, not hinder

knowledge

Emergent cuts jobs, executive role in business shake

Drastic changes should bring profitability, startup health insurers say

Police still searching for prisoner who escaped from NYC hospital

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Wegovy trial has doctors encouraged over new possibilities

leisure time

focus

hotspot

explore